Latest News about BMY
Recent news which mentions BMY
Why Ventyx Biosciences Is Trading Higher By 70%, Here Are 46 Stocks Moving In Monday's Mid-Day Session
September 12, 2022
From Benzinga
Bristol Myers Squibb Is a Must-Own Stock Right Now. Here's Why.
September 12, 2022
Tickers
BMY
From Motley Fool
QSR Stock Pops as Burger Kings Announces $400 Million Investment
September 12, 2022
From InvestorPlace
Adobe (ADBE) Stock Slips on Analyst Downgrade
September 12, 2022
From InvestorPlace
Buffett Still Loves Occidental, but Here's Monday's Mammoth Market Mover
September 12, 2022
From Motley Fool
From InvestorPlace
Here's Why Amgen Shares Are Diving
September 12, 2022
From Benzinga
HC Wainwright Cuts Price Target On This Stock By 73%, Also Check Out Other Major PT Changes Here
September 12, 2022
From Benzinga
Bristol-Myers Squibb, Carvana And Some Other Big Stocks Recording Gains In Today's Pre-Market Session
September 12, 2022
From Benzinga
From Benzinga
These three potential ‘naked swimmers’ threaten stocks and financial markets
September 12, 2022
From MarketWatch
Why Clovis Oncology Is Trading Higher By 14%; Here Are 28 Stocks Moving Premarket
September 12, 2022
From Benzinga
Bristol Myers' Deucravacitinib Scores FDA Approval For Plaque Psoriasis
September 12, 2022
From Benzinga
2 Top Stocks to Buy In September and Hold Forever
September 09, 2022
From Motley Fool
Is This Monster Stock On Its Way to Another Multibillion-Dollar Drug?
September 04, 2022
Tickers
BMY
From Motley Fool
5 Stocks That Michael Burry Just Dumped From His Portfolio
September 01, 2022
From InvestorPlace
From Benzinga
Why Bristol Myers Squibb Stock Is Slumping Today
August 29, 2022
From Motley Fool
Bristol Myers-JNJ Partnered Secondary Stroke Drug Misses Endpoint, But Companies See Enough Potential For Phase 3 Trials
August 29, 2022
From Benzinga
U.S.-China relations just got a whole lot better, boosting the prospects of these three stocks
August 28, 2022
From MarketWatch
Let's Talk About Michael Burry Selling Every Stock but One
August 26, 2022
From Motley Fool
From Motley Fool
Billionaires Are Scooping Up These 3 Beaten-Down Biotech Stocks
August 24, 2022
From Motley Fool
Here's Why This Dominant Income Stock Is a Buy
August 24, 2022
From Motley Fool
Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary
August 23, 2022
From Benzinga
Bristol Myers Squibb Secures Canadian Regulatory Nod For Lung Cancer Candidate In Neoadjuvant Setting
August 23, 2022
Tickers
BMY
From Benzinga
3 Reasons to Buy This High-Yield Dividend Stock
August 22, 2022
From Motley Fool
What's Next in Pfizer's M&A Ramp-Up?
August 20, 2022
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
